ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Upset At NCAB Over Why Decision, But Move On

February 8, 1991

In Brief: John Kovach Succeeds Moertel As Mayo CC Head; DEA Deputy Appointed; New NCAB Member Named

February 7, 1986

Fox Chase, UCLA, U. Washington Win Neutron Contracts

October 5, 1979

New AIDs System For Classification Increase By 1% Cases Reported

August 1, 1986

DCE Board Approves Concept For studies Of Thorotrast Exposure

November 16, 1990

New Research Ideas In Immodiagnosis Suggested For RFPs

October 21, 1977